Artra Group Corp
Artra Group Corp has a market price of 211 JPY per share, with a market capitalization of 2,166,280,874 JPY. The company's price-to-book ratio is 1.53, and its price-to-tangible-book ratio is also 1.53, indicating that the market values the company slightly above its book value. The enterprise value to EBITDA ratio is negative at -77.81, reflecting the company's current operating losses. The enterprise value to revenue ratio is 2.36, suggesting that the company is valued at a moderate multiple of its revenue. The company's profitability metrics are weak, with a return on equity of -2.47% and a return on assets of -0.83%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets. The operating income is negative at -31,649,000 JPY, and the net income is also negative at -34,900,000 JPY. The company's debt-to-equity ratio is 1.02, suggesting that it is financed almost equally by debt and equity. The current ratio of 1.88 indicates that the company has sufficient current assets to cover its current liabilities. Artra Group Corp's revenue is concentrated in a single business segment, with no disclosed geographic diversification. The company's total revenue for the period is 1,043,350,000 JPY, with a gross profit of 320,813,000 JPY. The company's operating and net losses suggest that it is not currently profitable and may be facing challenges in its core operations. The company's growth trajectory is uncertain, with no disclosed revenue growth or expansion plans. The company's operating and net losses indicate that it is not currently generating positive cash flows from operations. The company's liquidity position is medium, with a current ratio of 1.88, but its net cash position is negative after subtracting total debt. The company's debt-to-equity ratio of 1.02 suggests that it is using a significant amount of debt to finance its operations. The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may face liquidity challenges in the near term. The company's operating and net losses indicate that it is not currently profitable and may need to raise additional capital to fund its operations. The company's debt-to-equity ratio of 1.02 suggests that it is using a significant amount of debt to finance its operations. The company's recent financial performance, as reported in its latest financial statements, shows a revenue of 1,043,350,000 JPY and a gross profit of 320,813,000 JPY. The company's operating income is negative at -31,649,000 JPY, and its net income is also negative at -34,900,000 JPY. The company's liquidity position is medium, with a current ratio of 1.88, but its net cash position is negative after subtracting total debt. The company's debt-to-equity ratio of 1.02 suggests that it is using a significant amount of debt to finance its operations.
Business. Artra Group Corp is a Japanese biotechnology company that provides healthcare services and equipment, primarily operating in the healthcare facilities and services industry.
Classification. Artra Group Corp is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a high confidence level of 0.92.
- Artra Group Corp is currently unprofitable, with a negative return on equity and return on assets.
- The company's liquidity position is medium, with a current ratio of 1.88, but its net cash position is negative after subtracting total debt.
- The company's debt-to-equity ratio is 1.02, indicating a significant reliance on debt financing.
- The company's enterprise value to EBITDA ratio is negative, reflecting its current operating losses.
- The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification.
- The company's risk assessment indicates a medium liquidity risk and a low dilution risk.
- --
- ## RATIONALES
- Net cash is negative after subtracting total debt.